Patents by Inventor Conrad G. Chapman

Conrad G. Chapman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ASP2
    Patent number: 6870030
    Abstract: ASP2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing ASP2 polypeptides and polynucleotides in the design of protocols for the treatment of Alzheimer's Disease, cancer, and prohormone processing, among others, and diagnostic assays for such conditions.
    Type: Grant
    Filed: October 3, 2001
    Date of Patent: March 22, 2005
    Assignees: Smithkline Beecham Corporation, Smithkline Beecham plc
    Inventors: David J. Powell, Conrad G. Chapman, Kay Murphy, Trudi S. Smith
  • ASP2
    Publication number: 20030109022
    Abstract: ASP2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing ASP2 polypeptides and polynucleotides in the design of protocols for the treatment of Alzheimer's Disease, cancer, and prohormone processing, among others, and diagnostic assays for such conditions.
    Type: Application
    Filed: December 3, 2002
    Publication date: June 12, 2003
    Applicant: SmithKline Beecham Corporation
    Inventors: David J. Powell, Conrad G. Chapman, Kay Murphy, Trudi S. Smith
  • ASP2
    Publication number: 20030036112
    Abstract: ASP2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing ASP2 polypeptides and polynucleotides in the design of protocols for the treatment of AlzheiMer's Disease, cancer, and prohormone processing, among others, and diagnostic assays for such conditions.
    Type: Application
    Filed: October 3, 2001
    Publication date: February 20, 2003
    Inventors: David J. Powell, Conrad G. Chapman, Kay Murphy, Trudi S. Smith
  • ASP2
    Patent number: 6319689
    Abstract: ASP2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing ASP2 polypeptides and polynucleotides in the design of protocols for the treatment of Alzheimer's Disease, cancer, and prohormone processing, among others, and diagnostic assays for such conditions.
    Type: Grant
    Filed: January 20, 1998
    Date of Patent: November 20, 2001
    Assignees: SmithKline Beecham Corporation, SmithKline Beecham plc
    Inventors: David J Powell, Conrad G Chapman, Kay Murphy, Trudi S Smith
  • ASP1
    Patent number: 6162630
    Abstract: ASP1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing ASP1 polypeptides and polynucleotides in the design of protocols for the treatment of Alzheimers's Disease, cancer, and melanoma, among others, and diagnostic assays for such conditions.
    Type: Grant
    Filed: November 4, 1999
    Date of Patent: December 19, 2000
    Assignees: SmithKline Beecham Corporation, SmithKline Beecham plc
    Inventors: David J Powell, Christopher Southan, Conrad G Chapman, Joanne R Evans
  • ASP1
    Patent number: 6025180
    Abstract: ASP1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing ASP1 polypeptides and polynucleotides in the design of protocols for the treatment of Alzheimers's Disease, cancer, and melanoma, among others, and diagnostic assays for such conditions.
    Type: Grant
    Filed: October 6, 1997
    Date of Patent: February 15, 2000
    Assignees: SmithKline Beecham Corporation, SmithKline Beecham plc
    Inventors: David J Powell, Christopher Southan, Conrad G Chapman, Joanne R Evans